Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05949138 · ClinicalTrials.gov registry record
Clinical Data Collection and Evaluation of ECG-Less Cardiac CT
A clinical trial of Cardiac CT, sponsored by GE Healthcare.
- Completed
- Registry status
- 56
- Enrollment target
- 2
- Study locations
NCT05949138: Completed study of Cardiac CT, sponsored by GE Healthcare.
NCT05949138 is a study of Cardiac CT that has completed, run by GE Healthcare. The registered enrollment target is 56 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05949138, a study of Cardiac CT, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this study is to collect CT scan data without ECG-leads attached to the human subject. This data is intended to represent a typical range of clinical scenarios in which Cardiac CT imaging is used.
Primary Outcome
Number of Participants with raw investigational cardiac CT scan data
Conditions Studied
Interventions
- DEVICE ECG-Less Cardiac CT using SmartPhase
Study Locations (2)
Illinois
- University of Chicago - Chicago
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2023-11-03 |
What the finished NCT05949138 record still lists
NCT05949138 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 1 condition, with Cardiac CT appearing as the primary indexed condition, and to 1 intervention - of which ECG-Less Cardiac CT using SmartPhase is the first listed.
NCT05949138 reports a single indexed study location in Illinois, Washington.
Frequently Asked Questions
What is clinical trial NCT05949138 about?
NCT05949138 is a clinical study titled "Clinical Data Collection and Evaluation of ECG-Less Cardiac CT". The primary objective of this study is to collect CT scan data without ECG-leads attached to the human subject. This data is intended to represent a typical range of clinical scenarios in which Cardiac CT imaging is used.
What is the current status of trial NCT05949138?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2023-09-11. Estimated completion is 2023-11-03.
What conditions does trial NCT05949138 study?
This clinical trial studies the following conditions: Cardiac CT.
What interventions are being tested in trial NCT05949138?
The interventions under investigation include: ECG-Less Cardiac CT using SmartPhase (DEVICE).
Who is sponsoring clinical trial NCT05949138?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05949138 being conducted?
This trial has 2 study locations across Illinois, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI